Last Updated: May 3, 2026

Yichang Humanwell Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for YICHANG HUMANWELL

YICHANG HUMANWELL has twenty-four approved drugs.

Summary for Yichang Humanwell

US Patents:	0
Tradenames:	19
Ingredients:	19
NDAs:	24

Drugs and US Patents for Yichang Humanwell

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Yichang Humanwell	GUANFACINE HYDROCHLORIDE	guanfacine hydrochloride	TABLET, EXTENDED RELEASE;ORAL	213428-001	Nov 25, 2020	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Yichang Humanwell	NAPROXEN SODIUM	naproxen sodium	TABLET;ORAL	212033-001	Aug 30, 2019		OTC	No	No		⤷ Start Trial				⤷ Start Trial
Yichang Humanwell	MEMANTINE HYDROCHLORIDE	memantine hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	211100-001	Apr 2, 2021	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Yichang Humanwell	METFORMIN HYDROCHLORIDE	metformin hydrochloride	TABLET, EXTENDED RELEASE;ORAL	211052-002	Sep 24, 2018	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Yichang Humanwell	BUPROPION HYDROCHLORIDE	bupropion hydrochloride	TABLET, EXTENDED RELEASE;ORAL	211347-003	Oct 16, 2018	AB1	RX	No	No		⤷ Start Trial				⤷ Start Trial
Yichang Humanwell	NIACIN	niacin	TABLET, EXTENDED RELEASE;ORAL	212017-001	Jun 10, 2019		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
Yichang Humanwell	CARBAMAZEPINE	carbamazepine	TABLET, EXTENDED RELEASE;ORAL	219072-003	Jan 16, 2025	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Yichang Humanwell

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.